Unique ID issued by UMIN | UMIN000004307 |
---|---|
Receipt number | R000005163 |
Scientific Title | Clinical study of faropenem sodium to acute uncomplicated cystitis |
Date of disclosure of the study information | 2010/10/01 |
Last modified on | 2013/06/11 21:12:09 |
Clinical study of faropenem sodium to acute uncomplicated cystitis
Clinical study of faropenem sodium to acute uncomplicated cystitis
Clinical study of faropenem sodium to acute uncomplicated cystitis
Clinical study of faropenem sodium to acute uncomplicated cystitis
Japan |
acute uncomplicated cystitis
Urology |
Others
NO
To determine the optimal duration of administration with FRPM,microbiological
and clinical efficacy are examined in clinical study of FRPM.
Safety,Efficacy
Microbiological efficacy on 5-9 days after the finishing the administration
of FRPM
Clinical efficacy of FRPM
Evaluation of recurrence after treatment
Safety of FRPM
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
Institution is considered as a block.
YES
Central registration
2
Treatment
Medicine |
FRPM 200mg twice a day (600mg/day)is administrated to patients for 3 days
FRPM 200mg twice a day (600mg/day)is administrated to patients for 7 days
20 | years-old | <= |
Not applicable |
Female
Female outpatients over the age of 20,who are diagnosed with acute uncomplicated cystitis.
Patients who had any symptoms of pain on urination,frequent urination,urgency of urination or lower abdominal pain.
Patients who had pyuria with any categories below before the treatment;more than 10 WBC/mm3 in non-centrifuged urine specimen by testing equipment or calculated board, positive on non-centrifuged urine specimen by urine test strip or more than 5 WBC/mm3 in the urinary sediments.
Patients who had bacteriuria with more than 103 cfu/ml (Staphylococcus sp., Enterococcus faecalis, Streptococcus agalactiae or Enterobacteriaceae) before the treatment.
1.Patients infected with bacteria which can not expected efficacy of FRPM.
2.Patients with allergy to penicillins or chaparosporins.
3.Pregnant or lactating patients.
4.Patients with severe heart, liver or renal dysfunction.
5.Patients who had antimicrobial treatemt in 10 days
300
1st name | |
Middle name | |
Last name | Tetsuro Matsumoto |
University of Occupational and Environmental Health
Department of Urology
1-1,Iseigaoka,Yahata-nish-ku,kitakyushu,fukuoka,807-8555Japan
0936917446
1st name | |
Middle name | |
Last name |
University of Occupational and Environmental Health
Department of Urology
1-1,Iseigaoka,Yahata-nish-ku,kitakyushu,fukuoka,807-8555Japan
0936917446
npo crec net
npo crec net
Self funding
NO
細部医院(東京都)
げんき泌尿器科クリニック(東京都)
苫小牧王子総合病院(北海道)
国立病院機構函館病院泌尿器科(北海道)
川原腎・泌尿器科クリニック(鹿児島県)
まきのせ泌尿器科(鹿児島県)
下稲葉病院(鹿児島県)
肝属郡医師会立病院(鹿児島県)
医療法人山口皮フ・泌尿器科医院(福岡県)
医療法人かわい泌尿器科クリニック(福岡県)
医療法人泌尿器科いとうクリニック(福岡県)
医療法人山元泌尿器科医院(福岡県)
あいクリニック(宮城県)
泌尿器科皮膚科竹内クリニック(岐阜県)
しらね泌尿器科(広島県)
坂口泌尿器科クリニック(兵庫県)
たぐちクリニック(兵庫県)
やまもとクリニック泌尿器科(兵庫県)
鹿子木クリニック(兵庫県)
秋山泌尿器科(兵庫県)
いはらクリニック(兵庫県)
石川クリニック(兵庫県)
今井泌尿器科(兵庫県)
いまにし泌尿器科(兵庫県)
長久天満診療所(兵庫県)
まつむら泌尿器科(兵庫県)
しもがき泌尿器科クリニック(大阪府)
2010 | Year | 10 | Month | 01 | Day |
Unpublished
Completed
2010 | Year | 02 | Month | 05 | Day |
2010 | Year | 05 | Month | 01 | Day |
2010 | Year | 10 | Month | 01 | Day |
2013 | Year | 06 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005163
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |